Skip to main content
Top
Gepubliceerd in: Netherlands Heart Journal 5/2013

Open Access 01-05-2013 | Special Article

Microsphere embolisation as an alternative for alcohol in percutaneous transluminal septal myocardial ablation

Auteurs: P. A. Vriesendorp, N. M. Van Mieghem, W. B. Vletter, F. J. Ten Cate, P. L. de Jong, A. F. L. Schinkel, M. Michels

Gepubliceerd in: Netherlands Heart Journal | Uitgave 5/2013

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Background

Percutaneous transluminal septal myocardial ablation using microsphere embolisation is a new interventional technique to treat patients with hypertrophic obstructive cardiomyopathy.

Methods and results

In two patients, considered at high risk for myectomy, targeted septal perforators were occluded with microsphere embolisation instead of alcohol ablation to reduce left ventricular outflow gradient. In both cases the left ventricular outflow tract gradient was immediately reduced. No adverse events occurred.

Conclusion

This is the first clinical experience with Embozene® Microspheres in the Netherlands as an alternative for alcohol septal ablation. In both cases it resulted in immediate improvement in the haemodynamics, without any adverse events.
Literatuur
1.
go back to reference Maron MS, Olivotto I, Zenovich AG, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006;114:2232–9.PubMedCrossRef Maron MS, Olivotto I, Zenovich AG, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006;114:2232–9.PubMedCrossRef
2.
go back to reference Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:2761–96.PubMedCrossRef Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:2761–96.PubMedCrossRef
3.
go back to reference Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J. 2003;24:1965–91.PubMedCrossRef Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J. 2003;24:1965–91.PubMedCrossRef
4.
go back to reference Chen AA, Palacios IF, Mela T, et al. Acute predictors of subacute complete heart block after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2006;97:264–9.PubMedCrossRef Chen AA, Palacios IF, Mela T, et al. Acute predictors of subacute complete heart block after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2006;97:264–9.PubMedCrossRef
5.
go back to reference ten Cate FJ, Soliman OI, Michels M, et al. Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution. Circ Heart Fail. 2010;3:362–9.PubMedCrossRef ten Cate FJ, Soliman OI, Michels M, et al. Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution. Circ Heart Fail. 2010;3:362–9.PubMedCrossRef
6.
go back to reference Stampfl U, Radeleff B, Sommer C, et al. Midterm results of uterine artery embolization using narrow-size calibrated embozene microspheres. Cardiovasc Interv Radiol. 2011;34:295–305.CrossRef Stampfl U, Radeleff B, Sommer C, et al. Midterm results of uterine artery embolization using narrow-size calibrated embozene microspheres. Cardiovasc Interv Radiol. 2011;34:295–305.CrossRef
7.
go back to reference Stampfl U, Stampfl S, Bellemann N, et al. Experimental liver embolization with four different spherical embolic materials: impact on inflammatory tissue and foreign body reaction. Cardiovasc Interv Radiol. 2009;32:303–12.CrossRef Stampfl U, Stampfl S, Bellemann N, et al. Experimental liver embolization with four different spherical embolic materials: impact on inflammatory tissue and foreign body reaction. Cardiovasc Interv Radiol. 2009;32:303–12.CrossRef
8.
go back to reference Latsios G, Gerckens U, Mueller R, et al. Substitution of ethanol with specially designed microspheres in a TASH procedure. EuroIntervention. 2011;6:889–92.PubMedCrossRef Latsios G, Gerckens U, Mueller R, et al. Substitution of ethanol with specially designed microspheres in a TASH procedure. EuroIntervention. 2011;6:889–92.PubMedCrossRef
9.
go back to reference Carrel T, Schmidli J. Septal myectomy for hypertrophic obstructive cardiomyopathy: coil, boil and the role of rescue surgery. Eur J Cardiothorac Surg. 2009;36:210–1.PubMedCrossRef Carrel T, Schmidli J. Septal myectomy for hypertrophic obstructive cardiomyopathy: coil, boil and the role of rescue surgery. Eur J Cardiothorac Surg. 2009;36:210–1.PubMedCrossRef
10.
go back to reference Durand E, Mousseaux E, Coste P, et al. Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up. Eur Heart J. 2008;29:348–55.PubMedCrossRef Durand E, Mousseaux E, Coste P, et al. Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up. Eur Heart J. 2008;29:348–55.PubMedCrossRef
Metagegevens
Titel
Microsphere embolisation as an alternative for alcohol in percutaneous transluminal septal myocardial ablation
Auteurs
P. A. Vriesendorp
N. M. Van Mieghem
W. B. Vletter
F. J. Ten Cate
P. L. de Jong
A. F. L. Schinkel
M. Michels
Publicatiedatum
01-05-2013
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Netherlands Heart Journal / Uitgave 5/2013
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-013-0393-z

Andere artikelen Uitgave 5/2013

Netherlands Heart Journal 5/2013 Naar de uitgave

Rhythm puzzle - Answer

An atypical arrhythmia